US Pharmacopeia Recognizes Sami-Sabinsa for Reference Standards Contributions

Sabinsa, a raw material supplier to the nutraceutical and cosmeceutical industries, was recognized by the United States Pharmacopeia (USP) for providing candidate documentary and reference standards that assisted USP in reaching important milestones in 2023. USP’s Certificate of Appreciation also acknowledged Sabinsa’s outstanding contributions toward global public health by advancing USP standards.

The Sami-Sabinsa Group, which has been working with USP for more than 20 years on projects related to reference standards, has been a consistent source for USP of reference standards for the herbal industry, including all three actives of curcuminoids.

Reference standards are meticulously characterized substances utilized to assess the identity, potency, quality, and purity of dietary supplements and active pharmaceutical ingredients. They are the most critical requirement of any quantitative or qualitative analysis, without which one cannot provide a standardized product, according to Sabinsa.

“The Sami-Sabinsa Group manufactures and promotes standardized products with innovative molecules worldwide and understands the requirements when it comes to testing such molecules,” said Asha Ramesh, CEO of Sabinsa US. “We stepped up in providing unmatched quality reference standards to USP, a worldwide accepted, independent scientific nonprofit organization that focuses on building trust in the supply of safe, high-quality ingredients for dietary supplements.”